ADVERTISEMENT
Juvenile myoclonic epilepsy (JME) is a common form of epilepsy that usually is easily controlled by treatment with Depakote (valproate) alone. The syndrome usually requires lifelong treatment but with the right choice of medications, people who have...
Juvenile myoclonic epilepsy (JME) is a common epilepsy syndrome, which occurs in 7% of all people with epilepsy. If correctly diagnosed, up to 90% of people with JME become seizure-free on a regimen of medication, usually Depakote (valproate)....
Juvenile myoclonic epilepsy (JME) is not considered a severe condition. If the seizures are not controlled by medication, the doctor may have doubts about the diagnosis, the adequacy of treatment, or about the patient's lifestyle or compliance with...
Pfizer Inc announced in late October, 2003, that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA), seeking approval for a new seizure medicine called pregabalin (pree-gab-uh-lin). Pregabalin has been...
Adapted from: Holmes GL. Classification of seizures and the epilepsies. In: Schachter SC, Schomer DL, eds. The comprehensive evaluation and treatment of epilepsy. San Diego, CA: Academic Press; 1997. p. 1-36. With permission from Elsevier (www....

Pages